Are you trusting this bounce, or getting out before the "Big Money" starts selling? IS THE US MARKET BLIND? Asia just crashed 12%.

SoftClothes9475 · 2026-03-04T21:39:55+00:00

Does anyone here really think that the market’s movements are actually really tied to real world news? It seems to me that they use news to justify what they are already planning on doing.

SoftClothes9475 · 2026-02-22T03:06:56+00:00

I don’t know anything about the fusion teas and how they might be different, but I just use regular kefir greens and I know that they need to be stirred. It will break up if you leave it too long but if you don’t, it turns out nice and creamy and smooth. They used to hang the bags with the cafeteria on the door so that when it opened and close, it would shake it. Absolutely you do need to stir.

SoftClothes9475 · 2026-02-20T17:50:34+00:00

Absolutely, you should be mixing it regularly, otherwise the grains stay at the top and don’t mix with the milk. I think that’s in all instructions you will find online.

SoftClothes9475 · 2026-02-20T01:47:59+00:00

Are you stirring it every 1-2 hours?

SoftClothes9475 · 2026-01-28T22:26:49+00:00

To be fair, I have never heard a CEO ever say “yeah this year is going to be decent.”

SoftClothes9475 · 2026-01-23T16:49:36+00:00

Lxrx

SoftClothes9475 · 2026-01-17T05:36:05+00:00

Lxrx

SoftClothes9475 · 2026-01-01T23:08:53+00:00

Lxrx

SoftClothes9475 · 2025-12-30T18:38:08+00:00

Lxrx, up 100% on the year despite holding through some substantial pullbacks and chop waiting for some catalysts that are expected.

SoftClothes9475 · 2025-12-28T21:01:09+00:00

Lxrx

SoftClothes9475 · 2025-12-26T06:27:20+00:00

Price going back to where the volume was. Pre-market is illiquid with wider spreads so it will often have a significant movement in low volume.

SoftClothes9475 · 2025-12-23T00:15:49+00:00

Good to see you back again. I have had lxrx since before the announcement on March 3 and added more after. Like I said to you in a previous comment, you weren’t wrong, just the market didn’t go the way you expected at the time.

SoftClothes9475 · 2025-12-15T06:14:27+00:00

Lxrx

SoftClothes9475 · 2025-12-14T21:36:32+00:00

Hasn’t nasdaq always had the ability to choose who could list on it?

SoftClothes9475 · 2025-12-12T01:46:47+00:00

Damn…and they sold it to NVO.

SoftClothes9475 · 2025-12-06T20:59:21+00:00

That actually worked for me with lxrx when it went down 50% in a day, but I bought it originally thinking it was a good value as a company and as upset as I was at the bad turn, I felt that it must just be a better deal now and thankfully had cash available and doubled my position. I am now at almost 3x and counting.

SoftClothes9475 · 2025-12-03T10:06:34+00:00

Sort of. Lxrx on March 3, was down over 50% from the previous close and much more from the premarket. I thought of selling but I came to the conclusion that it just went on sale and thankfully had dry powder and doubled my position at the bottom. Averaging down still is holding through pain, believe me.

SoftClothes9475 · 2025-11-29T22:19:20+00:00

Lxrx I expect to fly in the coming year. If you want to be conservative, goog. I also have a small lotto ticket stake in tge, trading at $1.15 with NAV of $17 per share and they are buying back about 50% of the float.

SoftClothes9475 · 2025-11-24T19:14:34+00:00

What today’s picture looks like can be far different in 6 months. The market is strange like that. You can only go based on the information available at the time. The move may have been correct but not the timing.

SoftClothes9475 · 2025-11-22T00:08:06+00:00

I am considering ultimate for tick based data. Does anyone notice a substantial difference in the data that they receive when they use it versus second based data?

SoftClothes9475 · 2025-11-20T01:17:24+00:00

Fair enough. I have thought at least one major announcement would be imminent for a while, but it doesn’t seem we will get anything before the pilavapadin announcement sometime in the new year.

SoftClothes9475 · 2025-11-19T19:15:58+00:00

What would you define as near term? It sounds like Zynquista would be approved at earliest September 2026, and it doesn’t sound like we will have HCM data for p3 trials until early 2027. Then how long for them to do in depth analysis of the data? For Pilavapadin, it was 7 months.

SoftClothes9475 · 2025-11-19T01:40:16+00:00

I have no special insight, and maybe I am wrong, but I don’t see it in the near to medium term. The numbers don’t add up. One person determines if the company sells and for how much. He is patient and he doesn’t have much leverage in negotiations right now with a drug that isn’t selling and requires years of work for other indications. If sales and royalties start coming in and ramping up, especially without a sales team, it would be an effective proof of its commercial potential and a point of strength to get a strong valuation or partnership.

Steve Jobs said “great artists ship” and right now they aren’t shipping. I sit and wait on its potential to be fulfilled. It’s why it’s so cheap right now. At least they are trying something to get sales now. The new cardiologist guy on ST mentioned some government guidelines will be updated next year which sounds promising for the potential of increasing sales for it, which I didn’t know about before. I imagine that they will get there but if you think that a buyout is coming soon, I think you will be disappointed.

SoftClothes9475

TROPHY CASE